miércoles, 25 de noviembre de 2015

NIH-Sponsored Clinical Trial of Chikungunya Vaccine Opens

NIH-Sponsored Clinical Trial of Chikungunya Vaccine Opens

NIH: National Institute of Allergy and Infectious Diseases



Tuesday Nov. 24, 2015

NIH-sponsored clinical trial of chikungunya vaccine opens

chikungunya virus



An experimental vaccine to protect against the mosquito-borne illness chikungunya is being tested in a Phase 2 trial sponsored by the National Institutes of Health. In a phase 1 trial of the candidate vaccine, developed by researchers at the National Institute of Allergy and Infectious Diseases, all 25 volunteers developed robust immune responses to the vaccine. The new trial will enroll 400 healthy adults at six sites in the Caribbean.
Read More

No hay comentarios:

Publicar un comentario